Capricorn Healthtech Fund II
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Late Seed, Series A, Series B
Geographical Focus
United Kingdom, Germany, France, Italy, Denmark, Switzerland, Spain, Luxembourg, Ireland, Austria, Netherlands, Hungary, Portugal, Sweden, Belgium, Norway, Finland, Poland, Czech Republic, Slovakia, Romania
Industries Focus
- Healthcare
- Artificial Intelligence
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Medtech
- Machine Learning
- Biotechnology
- Clinical Trials
- Regenerative Medicine
- Data Analytics
- E-health
- Health IT
- Telemedicine
- Medical Imaging
- Health Software Platforms
- Health Applications
- Wearable Health Devices
- Health Data Management
Investment Size:
1,000,000 to 5,000,000 USD
Investor Details Founded: 2025
Capricorn Healthtech Fund II is a Belgian venture capital firm dedicated to investing in innovative health technology companies across Europe. The fund focuses on digital health and medtech sectors, aiming to support healthcare transformers that enhance accessibility and efficiency in healthcare delivery. With a commitment to personalized and value-based healthcare, the fund seeks to address the challenges posed by aging populations and the prevalence of chronic diseases by investing in technologies that improve patient outcomes and reduce costs.
The fund operates as a pan-European entity, targeting investments in 10-15 companies at the late seed to Series B stages. Initial investment tickets range from €1 million to €5 million, with a particular emphasis on the Benelux region, including Belgium and the Netherlands. The investment strategy encompasses both traditional medical devices and novel health software platforms and applications, reflecting a comprehensive approach to the evolving healthcare landscape.
Capricorn Healthtech Fund II is managed by Capricorn Partners, an independent European manager of venture capital and equity funds. The team comprises experienced investment managers with deep technology expertise and a broad industrial experience. The fund's commitment to innovation and societal impact is central to its operations, aiming to contribute to a healthier, more sustainable future by supporting entrepreneurs and their technologies that positively affect people's lives.
Requirements
- European companies
- Digital health or medtech focus
- Proven technology base
- Health economic benefit
- Late seed to Series B stage
- Initial tickets from €1M to €5M
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Aspect Analytics
- icometrix
- Cartagenia
- Bluebee
- Sequana Medical
- Mainstay Medical
- Ogeda
Claim this Investor
Are you an official representative of Capricorn Healthtech Fund II?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim